Dr. Darrin M. Disley OBE - CEO

Dr. Darrin M. Disley OBE

Chief Executive Officer

Darrin is a renowned scientist, entrepreneur, angel investor and enterprise champion who has started, grown, or invested in over 40 start-up life science, technology and social enterprises, raising $600 million USD in business financing and closing $700 million USD in commercial deals. He was CEO of Horizon Discovery Group plc for 11 years, during which he led the Company from start-up through a $113 million USD IPO, and rapid scale-up powered by multiple acquisitions of US peer companies to become a global market leader in gene editing and gene modulation technologies. He was awarded a lifetime Queen’s Award for Enterprise Promotion in 2016 for his work in promoting enterprise across the UK and appointed OBE in 2018 for his services to business and enterprise in the healthcare sector.

Chasing the Holy Grail of Cell Therapy  Labiotech featuring Dr. Darrin M. Disley 

Dr. Louise Modis - CSO

Dr. Louise Modis

Chief Scientific Officer

Louise is an accomplished scientific leader with over 20 years’ experience in pre-clinical and clinical therapeutic research across various modalities and therapeutic areas. Formerly Vice President of Immunology Research at GlaxoSmithKline (GSK), she led the generation and advancement of a pipeline of assets from target identification through to clinical proof-of-concept studies. In her career, Louise has led research teams at Boehringer Ingelheim Pharmaceuticals and Millennium Pharmaceuticals (now Takeda), as well as represented GSK on the board of Sitryx.

Louise completed her PhD in Developmental Hematology at EMBL, Heidelberg, Germany and postdoctoral fellowship at Harvard University, Boston.

The Cell Reprogrammer – The Medicine Maker featuring Dr. Louise Modis

Joe Foster - COO

Joe Foster

Chief Operating Officer

Joe began his career at Horizon Discovery Group plc working within the corporate development team gaining experience in business planning, licensing, technology evaluation and M&A analysis, before becoming Dr. Jonathan Milner’s (Co-founder of Abcam plc) Portfolio Manager where he built and managed a complex portfolio of more than 40 early-stage life science companies. Joe holds a degree in molecular and cellular biology from the University of Bath and an MPhil in business management from the University of Cambridge.

Leading the Movement Towards Direct Cell Conversion – Technology Networks featuring Joe Foster. 

Dr. Darrin M. Disley OBE - CEO
Dr. Louise Modis - CSO
Joe Foster - COO


Leadership Team